- Home
- TECH vs RLAY Comparison
TECH vs RLAY Comparison
Compare TECH & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- RLAY
- Stock Information
- Founded
- TECH 1976
- RLAY 2015
- Country
- TECH United States
- RLAY United States
- Employees
- TECH N/A
- RLAY N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TECH Health Care
- RLAY Health Care
- Exchange
- TECH Nasdaq
- RLAY Nasdaq
- Market Cap
- TECH 8.0B
- RLAY N/A
- IPO Year
- TECH 1989
- RLAY 2020
- Fundamental
- Price
- TECH $48.10
- RLAY $2.69
- Analyst Decision
- TECH Buy
- RLAY Strong Buy
- Analyst Count
- TECH 9
- RLAY 10
- Target Price
- TECH $81.25
- RLAY $19.33
- AVG Volume (30 Days)
- TECH 2.2M
- RLAY 3.0M
- Earning Date
- TECH 05-07-2025
- RLAY 05-01-2025
- Dividend Yield
- TECH 0.63%
- RLAY N/A
- EPS Growth
- TECH N/A
- RLAY N/A
- EPS
- TECH 0.98
- RLAY N/A
- Revenue
- TECH $1,196,016,000.00
- RLAY $10,007,000.00
- Revenue This Year
- TECH $8.19
- RLAY N/A
- Revenue Next Year
- TECH $8.85
- RLAY $420.18
- P/E Ratio
- TECH $52.13
- RLAY N/A
- Revenue Growth
- TECH 4.46
- RLAY N/A
- 52 Week Low
- TECH $46.44
- RLAY $1.78
- 52 Week High
- TECH $85.57
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- TECH 33.97
- RLAY 48.08
- Support Level
- TECH $46.44
- RLAY $1.82
- Resistance Level
- TECH $53.00
- RLAY $2.81
- Average True Range (ATR)
- TECH 3.30
- RLAY 0.26
- MACD
- TECH -0.27
- RLAY 0.09
- Stochastic Oscillator
- TECH 13.00
- RLAY 88.41
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.